Evidence map›Paper›PMID 31578346›Full record

ArticleScientific reports2019

Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.

T N Aung, S Nourmohammadi, Z Qu, Y Harata-Lee, J Cui, H Y Shen, A J Yool, T Pukala, Hong Du, R D Kortschak and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

T N AungDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID http://orcid.org/0000-0003-4150-0426
S NourmohammadiAdelaide Medical School, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Z QuDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
Y Harata-LeeDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
J CuiDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
H Y ShenDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
A J YoolAdelaide Medical School, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID http://orcid.org/0000-0003-1283-585X
T PukalaSchool of Physical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.ORCID http://orcid.org/0000-0001-7391-1436
Hong DuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, P.R. China.
R D KortschakDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia.
W WeiBeijing Zhendong Guangming Pharmaceutical Research Institute, Shanxi - Zhendong Pharmaceutical Co Ltd, Beijing, P.R. China.
D L AdelsonDepartment of Molecular and Biomedical Science, School of Biological Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia. david.adelson@adelaide.edu.au.ORCID http://orcid.org/0000-0003-2404-5636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used computational and experimental biology approaches to identify candidate mechanisms of action of aTraditional Chinese Medicine, Compound Kushen Injection (CKI), in a breast cancer cell line (MDA-MB-231). Because CKI is a complex mixture of plant secondary metabolites, we used a high-performance liquid chromatography (HPLC) fractionation and reconstitution approach to define chemical fractions required for CKI to induce apoptosis. The initial fractionation separated major from minor compounds, and it showed that major compounds accounted for little of the activity of CKI. Furthermore, removal of no single major compound altered the effect of CKI on cell viability and apoptosis. However, simultaneous removal of two major compounds identified oxymatrine and oxysophocarpine as critical with respect to CKI activity. Transcriptome analysis was used to correlate compound removal with gene expression and phenotype data. Many compounds in CKI are required to trigger apoptosis but significant modulation of its activity is conferred by a small number of compounds. In conclusion, CKI may be typical of many plant based extracts that contain many compounds in that no single compound is responsible for all of the bioactivity of the mixture and that many compounds interact in a complex fashion to influence a network containing many targets.

Indexed as

Antineoplastic AgentsApoptosisBreast NeoplasmsCell CycleCell Line, TumorCell ProliferationCell SurvivalChromatography, High Pressure LiquidCytokinesDrugs, Chinese HerbalFemaleGene Expression Regulation, NeoplasticHumansMedicine, Chinese TraditionalSignal TransductionSmilacaceaeAntineoplastic AgentsCytokinesDrugs, Chinese Herbalkushen

Identifiers

PMID31578346
PMCPMC6775143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.